TESPI(THROMBOLYSIS IN ELDERLY STROKE PATIENTS IN ITALY): RANDOMIZED CONTROLLED TRIAL OF ALTEPLASE VERSUS STANDARD TREATMENT IN PATIENTS AGED >80 YEARS WITHIN 3HRS AFTER STROKE ONSET
World Stroke Academy. Lorenzano S. May 16, 2017; 183380 Disclosure(s): Honoraria and consulting from Boehringer Ingelheim. Honoraria from Quintiles IMS, Bayer, Daichii Sankyo.
Svetlana Lorenzano
Svetlana Lorenzano
Login now to access Regular content available to all registered users.

Access to Premium content is currently a membership benefit.

You may also access WSO content "anytime, anywhere" with the FREE World Stroke Academy App for iOS and Android.
Discussion Forum (0)
Rate & Comment (0)
Code of conduct/disclaimer available in General Terms & Conditions

By continuing to browse or by clicking “Accept Terms & all Cookies”, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies